尿道抵抗指数(URI):尿道閉塞診断のための新規パラメータ (URI)
尿道抵抗指数(URI):尿道閉塞の非侵襲的診断における新しい尿流測定パラメータ
This prospective observational study aims to evaluate the diagnostic accuracy of a new, non-invasive uroflowmetry parameter called the Urethral Resistive Index (URI) for detecting urethral stricture in men. Currently, diagnosing urethral stricture often requires invasive procedures like surgery or pressure-flow studies. This research seeks to develop URI as a practical and painless screening tool that could reduce the need for such invasive interventions.
Study Procedures:
A total of 60 male participants (30 with suspected urethral stricture and 30 healthy volunteers) will be enrolled. Participants will undergo two standard, non-invasive uroflowmetry (voiding) tests. The first test is a routine natural voiding session. The second test involves a "forced voiding" (Valsalva maneuver) once the participant feels a sufficient urge to urinate again. The URI is then calculated by comparing the flow rates of these two sessions.
Goals and Benefits: The primary goal is to determine the optimal "cut-off" value of the URI that accurately identifies a surgically proven urethral stricture. By demonstrating URI's effectiveness, the study aims to expedite the diagnostic process and spare patients from unnecessary invasive tests. The procedure involves minimal risk, primarily temporary discomfort or psychological stress during the voiding tests
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
This methodological study is designed as a prospective, cross-sectional, and observational diagnostic accuracy study. The primary objective is to evaluate the clinical validity of the Urethral Resistive Index (URI), a novel non-invasive parameter, in the diagnosis of urethral stricture.
Study Population and Groups:
The study will include a total of 60 male participants aged between 18 and 80 years.
Stricture Group (n=30): Patients planned for surgery (urethroplasty or internal urethrotomy) due to suspected urethral stricture, where the presence of the stricture is confirmed intraoperatively.
Control Group (n=30): Healthy male volunteers without lower urinary tract symptoms, matched for age.
Methodology: The study focuses on comparing standard uroflowmetry with "forced" uroflowmetry using the Valsalva maneuver. All clinical and uroflowmetric parameters will be collected at the Ankara Bilkent City Hospital Urology Clinic.
Natural Uroflowmetry: Participants will perform a standard uroflowmetry test. Forced Uroflowmetry: After reaching sufficient bladder fullness again, participants will perform a second test using the Valsalva maneuver (forced voiding).
Calculation: The URI will be calculated using the formula:
URI= Qmax,forced/ Qmax,normal
Statistical Analysis: The diagnostic performance of the URI will be evaluated using Receiver Operating Characteristic (ROC) curve analysis. The Area Under the Curve (AUC) will be calculated, and the optimal cut-off value for determining urethral stricture will be identified with corresponding sensitivity and specificity values. Correlation between URI and clinical symptom scores, such as the International Prostate Symptom Score (IPSS), will also be analyzed.
研究の種類
研究の種類
入学 (推定)
入学
連絡先と場所
研究連絡先
研究連絡先
- 名前:Yusuf Gökkurt
- 電話番号:+90-506-791-0557
- メール:yusufgokkurt@gmail.com
研究場所
-
-
Universiteler
-
Ankara、Universiteler、トルコ(Türkiye)、06800
- 募集
- Ankara Bilkent City Hospital
-
コンタクト:
- Yusuf Gökkurt, MD
- 電話番号:+90 506 791 0557
- メール:yusufgokkurt@gmail.com
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
The study population consists of 60 male participants, aged 18 to 80 years, recruited from the Urology Outpatient Clinic at Ankara Bilkent City Hospital. The population is divided into two distinct groups: a Stricture Group (n=30) comprising patients with suspected urethral stricture whose diagnosis is confirmed intraoperatively during scheduled surgery, and a Control Group (n=30) comprising healthy male volunteers with a similar age distribution and no lower urinary tract symptoms. Participants are selected based on their clinical presentation and willingness to undergo a specialized two-stage uroflowmetry protocol.
説明
Inclusion Criteria:
- Male participants aged between 18 and 80 years.
- For the Stricture Group: Patients scheduled for surgery (urethroplasty or internal urethrotomy) due to suspected urethral stricture, where the diagnosis is confirmed intraoperatively.
- For the Control Group: Healthy male volunteers without any lower urinary tract symptoms.
- Voluntary signing of the Informed Consent Form.
Exclusion Criteria:
- Voiding volume less than 150 mL.
- Causes of obstruction other than stricture, such as Benign Prostatic Hyperplasia (BPH).
- Diagnosis of neurogenic bladder dysfunction or a history of neurological disease affecting bladder function.
- Presence of severe comorbidities.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:PROSPECTIVE
グループ/コホートの数
コホートと介入
グループ/コホートグループ/コホート |
介入・治療介入・治療 |
|---|---|
|
Stricture Group
Patients with suspected urethral stricture scheduled for surgery (urethroplasty or internal urethrotomy), with the diagnosis confirmed intraoperatively. |
Performing natural and forced (Valsalva) uroflowmetry sessions to calculate the Urethral Resistive Index. |
|
Control Group
Healthy male volunteers in a similar age range as the stricture group, without any lower urinary tract symptoms. |
Performing natural and forced (Valsalva) uroflowmetry sessions to calculate the Urethral Resistive Index. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Urethral Resistive Index (URI)
時間枠:At the time of the uroflowmetry procedure (Baseline)
|
A novel non-invasive uroflowmetric parameter calculated to assess the resistance of the urethra during voiding. It is derived using the formula: URI=Qmax,natural/Qmax,forced. |
At the time of the uroflowmetry procedure (Baseline)
|
協力者と研究者
出版物と役立つリンク
一般刊行物
- Kranse R, van Mastrigt R. Bladder outlet resistance. J Urol. 2003 Mar;169(3):1007-10. doi: 10.1097/01.ju.0000052693.58772.23.
- Spyropoulos E, Galanakis I, Deligiannis D, Spyropoulou A, Kotsiris D, Panagopoulos A, Mavrikos S. Flow resistive forces index (QRF): Development and clinical applicability assessment of a novel measure of bladder outlet resistance, aiming to enhance the diagnostic performance of uroflowmetry. Low Urin Tract Symptoms. 2020 Sep;12(3):190-197. doi: 10.1111/luts.12301. Epub 2020 Jan 30.
- Krukowski J, Kaluzny A, Klacz J, Piatkowska A, Matuszewski M. Evaluation of non-invasive tests as diagnostic tools in assessment of bladder outlet obstruction severity in men with anterior urethral stricture. Cent European J Urol. 2021;74(3):422-428. doi: 10.5173/ceju.2021.3.153.R1. Epub 2021 Jul 27.
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
その他の研究ID番号
- TABED 1/2090/2026
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
To protect participant privacy and maintain data confidentiality according to local institutional regulations
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。